Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to build complex nitrogen-containing heterocycles. Its pyridine and morpholine moieties make it valuable for developing bioactive molecules, including kinase inhibitors and central nervous system agents. The boronate ester group enables efficient carbon-carbon bond formation under mild conditions, offering high selectivity and yield in drug discovery and development. Commonly employed in the preparation of small-molecule therapeutics and functionalized heteroaromatic compounds for medicinal chemistry research.